439 related articles for article (PubMed ID: 12842921)
41. The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats.
Seyfarth T; Gerbershagen HP; Giessler C; Leineweber K; Heinroth-Hoffmann I; Pönicke K; Brodde OE
J Mol Cell Cardiol; 2000 Dec; 32(12):2315-26. PubMed ID: 11113007
[TBL] [Abstract][Full Text] [Related]
42. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
[TBL] [Abstract][Full Text] [Related]
43. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
44. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
45. Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats.
Maier LS; Wahl-Schott C; Horn W; Weichert S; Pagel C; Wagner S; Dybkova N; Müller OJ; Näbauer M; Franz WM; Pieske B
Cardiovasc Res; 2005 Sep; 67(4):636-46. PubMed ID: 15932750
[TBL] [Abstract][Full Text] [Related]
46. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.
Lourenço AP; Roncon-Albuquerque R; Brás-Silva C; Faria B; Wieland J; Henriques-Coelho T; Correia-Pinto J; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1587-94. PubMed ID: 16679394
[TBL] [Abstract][Full Text] [Related]
47. Maturation-dependent differences in regulation of sarcoplasmic reticulum Ca(2+) ATPase in sheep myocardium in response to pressure overload: a possible mechanism for maturation-dependent systolic and diastolic dysfunction.
Aoyagi T; Fujii AM; Flanagan MF; Arnold L; Mirsky I; Izumo S
Pediatr Res; 2001 Aug; 50(2):246-53. PubMed ID: 11477211
[TBL] [Abstract][Full Text] [Related]
48. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
[TBL] [Abstract][Full Text] [Related]
49. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of sarco(endo)plasmic reticulum Ca2+-ATPase differentially regulates contractile function in cardiac myocytes from normotensive and spontaneously hypertensive rats: role of Ca2+ regulatory proteins.
Li SY; Golden KL; Jiang Y; Wang GJ; Privratsky JR; Zhang X; Eason AR; Culver B; Ren J
Cell Biochem Biophys; 2005; 42(1):1-12. PubMed ID: 15673924
[TBL] [Abstract][Full Text] [Related]
51. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process.
Angelini A; Castellani C; Ravara B; Franzin C; Pozzobon M; Tavano R; Libera LD; Papini E; Vettor R; De Coppi P; Thiene G; Vescovo G
J Heart Lung Transplant; 2011 Nov; 30(11):1281-93. PubMed ID: 21989772
[TBL] [Abstract][Full Text] [Related]
52. Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.
Linck B; Bokník P; Baba HA; Eschenhagen T; Haverkamp U; Jäckel E; Jones LR; Kirchhefer U; Knapp J; Läer S; Müller FU; Schmitz W; Scholz H; Syska A; Vahlensieck U; Neumann J
J Pharmacol Exp Ther; 1998 Jul; 286(1):531-8. PubMed ID: 9655899
[TBL] [Abstract][Full Text] [Related]
53. Altered sarcoplasmic reticulum Ca2+ ATPase gene expression in congestive heart failure: effect of chronic norepinephrine infusion.
Lai LP; Raju VS; Delehanty JM; Yatani A; Liang CS
J Mol Cell Cardiol; 1998 Jan; 30(1):175-85. PubMed ID: 9500874
[TBL] [Abstract][Full Text] [Related]
54. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
El-Armouche A; Boknik P; Eschenhagen T; Carrier L; Knaut M; Ravens U; Dobrev D
Circulation; 2006 Aug; 114(7):670-80. PubMed ID: 16894034
[TBL] [Abstract][Full Text] [Related]
55. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
56. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure.
Mercadier JJ; Lompré AM; Duc P; Boheler KR; Fraysse JB; Wisnewsky C; Allen PD; Komajda M; Schwartz K
J Clin Invest; 1990 Jan; 85(1):305-9. PubMed ID: 2136864
[TBL] [Abstract][Full Text] [Related]
57. Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide.
Chen L; Gan XT; Haist JV; Feng Q; Lu X; Chakrabarti S; Karmazyn M
J Pharmacol Exp Ther; 2001 Aug; 298(2):469-76. PubMed ID: 11454907
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Nakazawa H; Hori M; Ozaki H; Karaki H
Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
[TBL] [Abstract][Full Text] [Related]
59. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure.
Leineweber K; Brandt K; Wludyka B; Beilfuss A; Pönicke K; Heinroth-Hoffmann I; Brodde OE
Circ Res; 2002 Nov; 91(11):1056-62. PubMed ID: 12456492
[TBL] [Abstract][Full Text] [Related]
60. Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy.
Kimura K; Ieda M; Kanazawa H; Yagi T; Tsunoda M; Ninomiya S; Kurosawa H; Yoshimi K; Mochizuki H; Yamazaki K; Ogawa S; Fukuda K
Circ Res; 2007 Jun; 100(12):1755-64. PubMed ID: 17495227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
